BANK OF AMERICA CORP /DE/ - BLUEBIRD BIO INC ownership

BLUEBIRD BIO INC's ticker is BLUE and the CUSIP is 09609G100. A total of 155 filers reported holding BLUEBIRD BIO INC in Q2 2022. The put-call ratio across all filers is 1.50 and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of BLUEBIRD BIO INC
ValueSharesWeighting
Q3 2023$3,699,717
-41.9%
1,217,012
-37.1%
0.00%
-100.0%
Q2 2023$6,364,831
+1.8%
1,934,599
-1.6%
0.00%0.0%
Q1 2023$6,249,568
+29.0%
1,965,273
+180.7%
0.00%0.0%
Q4 2022$4,845,654
+29.0%
700,239
+18.0%
0.00%
Q3 2022$3,756,000
+1222.5%
593,499
+766.5%
0.00%
Q2 2022$284,000
-91.1%
68,494
-89.6%
0.00%
Q1 2022$3,186,000
-54.1%
657,029
-5.5%
0.00%
-100.0%
Q4 2021$6,942,000
+220.6%
694,929
+513.4%
0.00%
Q3 2021$2,165,000
-63.0%
113,287
-38.1%
0.00%
-100.0%
Q2 2021$5,855,000
-27.9%
183,087
-32.0%
0.00%0.0%
Q1 2021$8,124,000
-40.6%
269,424
-14.8%
0.00%
-50.0%
Q4 2020$13,685,000
-41.4%
316,277
-27.0%
0.00%
-33.3%
Q3 2020$23,372,000
-5.9%
433,222
+6.5%
0.00%
-25.0%
Q2 2020$24,828,000
+74.8%
406,750
+31.6%
0.00%
+100.0%
Q1 2020$14,202,000
-8.7%
309,022
+74.3%
0.00%0.0%
Q4 2019$15,561,000
-35.8%
177,340
-32.8%
0.00%
-50.0%
Q3 2019$24,234,000
-62.3%
263,935
-47.8%
0.00%
-60.0%
Q2 2019$64,272,000
-47.8%
505,274
-35.5%
0.01%
-47.4%
Q1 2019$123,226,000
+176.2%
783,225
+74.1%
0.02%
+171.4%
Q4 2018$44,619,000
+60.9%
449,772
+136.8%
0.01%
+75.0%
Q3 2018$27,733,000
+13.3%
189,948
+21.8%
0.00%0.0%
Q2 2018$24,467,000
+16.3%
155,890
+26.6%
0.00%0.0%
Q1 2018$21,030,000
-3.0%
123,166
+1.2%
0.00%0.0%
Q4 2017$21,675,000
+17.0%
121,700
-9.7%
0.00%
+33.3%
Q3 2017$18,521,000
+108.9%
134,845
+59.8%
0.00%
+50.0%
Q2 2017$8,867,000
+33.9%
84,403
+15.8%
0.00%
+100.0%
Q1 2017$6,624,000
-26.9%
72,862
-50.4%
0.00%
-50.0%
Q4 2016$9,060,000
+7.2%
146,822
+17.8%
0.00%0.0%
Q3 2016$8,448,000
+49.7%
124,634
-4.4%
0.00%
+100.0%
Q2 2016$5,645,000
-16.0%
130,401
-17.5%
0.00%
-50.0%
Q1 2016$6,718,000
-40.3%
158,070
-9.8%
0.00%
-33.3%
Q4 2015$11,256,000
+17.2%
175,271
+56.1%
0.00%
+50.0%
Q3 2015$9,605,000
-66.5%
112,284
-34.1%
0.00%
-77.8%
Q2 2015$28,698,000
+423.1%
170,443
+275.2%
0.01%
+350.0%
Q1 2015$5,486,000
+45.1%
45,431
+10.2%
0.00%
+100.0%
Q4 2014$3,781,000
+106.5%
41,224
-19.3%
0.00%0.0%
Q3 2014$1,831,000
-5.7%
51,062
+1.4%
0.00%0.0%
Q2 2014$1,942,000
+17.9%
50,342
-30.5%
0.00%0.0%
Q1 2014$1,647,000
+228.7%
72,432
+202.7%
0.00%
Q4 2013$501,000
-46.8%
23,926
-31.5%
0.00%
Q3 2013$941,00034,9270.00%
Other shareholders
BLUEBIRD BIO INC shareholders Q2 2022
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 5,910,687$24,470,0003.71%
Monaco Asset Management SAM 306,142$1,267,0000.55%
Parametrica Management Ltd 90,105$374,0000.41%
Kamunting Street Capital Management, L.P. 55,200$229,0000.31%
Birchview Capital, LP 98,000$406,0000.30%
Kamunting Street Capital Management, L.P. 35,000$145,0000.20%
PDT Partners, LLC 519,477$2,151,0000.19%
Graham Capital Management, L.P. 781,912$3,237,0000.13%
CAXTON ASSOCIATES LP 220,154$911,0000.09%
Baker Brothers Advisors 2,499,715$10,349,0000.06%
View complete list of BLUEBIRD BIO INC shareholders